Franklin Genomic Advancements ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.50
資產淨值: 33.36
成立日期: 25/02/2020
 
分析
市值分佈:
68.74%
大市值
13.54%
中市值
0.89%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:56) 總持有投資項目: 52  
0%
 
100%
     10大 (41.46%)
代號 名稱 佔比% 持有日期
NTRANatera6.6028/02/2026
GHGuardant Health6.5728/02/2026
KRYSKrystal Biotech5.4228/02/2026
BBIOBridgeBio Pharma3.6128/02/2026
ADPTAdaptive Biotechnologies Corp3.4428/02/2026
LGNDLigand Pharmaceuticals3.3528/02/2026
AZNAstraZeneca PLC3.3328/02/2026
ALNYAlnylam Pharmaceuticals3.1828/02/2026
VRTXVertex Pharmaceuticals3.1728/02/2026
LLYEli Lilly & Co2.7828/02/2026
MEDPMedpace Holdings2.6728/02/2026
REGNRegeneron Pharmaceuticals2.5128/02/2026
CTVACorteva2.4628/02/2026
EXASExact Sciences Corp2.4228/02/2026
TEMTempus AI Inc.2.1928/02/2026
IONSIonis Pharmaceuticals2.1528/02/2026
BNTXBioNTech SE American Depositary Share2.1328/02/2026
ARGNFArgen X NV1.5928/02/2026
NBIXNeurocrine Biosciences1.5928/02/2026
WGSGeneDx Holdings Corp1.4728/02/2026
 1    2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.